Britannia Life Sciences Inc.
BLAB.CNCNQHealthcare● Active
$0.09
+$0.00(+0.00%)
Market Cap$13791619
P/E Ratio—
52W High$0.14
52W Low$0.06
Britannia Life Sciences Inc. (BLAB.CN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLAB.CN · earnings · updated Jun 10, 2026
Latest Earnings
Q4 FY2023Report Date: Dec 31, 2023EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Dec 31, 2023
After Market Close
BLAB.CN reports quarterly as a CNQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2023 | Dec 31, 2023 | — | $0.00 | — | $0.00B | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | $0.00 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.03 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.01 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.01 | — | $0.00B | — | — |
| — Q1 FY2021 | Mar 31, 2021 | — | $0.00 | — | $0.00B | — | — |
Q4 FY2023
Dec 31, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 30, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Sep 30, 2022
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 30, 2021
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2021
Mar 31, 2021
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for BLAB.CN.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Dec 31, 2023 | — | $0.08 | $0.09 | +13.33% |
| — Q3 FY2023 | Sep 30, 2023 | — | $0.07 | $0.07 | +7.69% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.12 | $0.12 | +0.00% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.10 | $0.10 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.07 | $0.08 | +14.29% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.13 | $0.13 | +0.00% |
| — Q2 FY2021 | Jun 30, 2021 | — | No price data | $0.27 | — |
| — Q1 FY2021 | Mar 31, 2021 | — | No price data | $0.27 | — |
Q4 FY2023+13.33%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.09
Q3 FY2023+7.69%
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q4 FY2022+14.29%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.08
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.13
Q2 FY2021—
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$0.27
Q1 FY2021—
Report Date
Mar 31, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$0.27
Beat Rate0 / 8 quarters
Largest Move+14.29% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLAB.CN ends December
Britannia Life Sciences Inc. (BLAB.CN) most recently reported earnings on December 31, 2023 for Q4 FY2023, posting EPS of $0.00 (in line with the analyst consensus of —).
Each quarter, investors track BLAB.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLAB.CN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLAB.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLAB.CN earnings · 4 questionsBritannia Life Sciences Inc.'s next earnings report is expected around TBD. BLAB.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLAB.CN historically reports after market close (AMC).
BLAB.CN earnings datewhen is BLAB.CN earningsBLAB.CN next earnings datewhen does BLAB.CN report earningsBLAB.CN earnings calendar
▸ Source: FMP · Britannia Life Sciences Inc. SEC filings · US GAAP · Britannia Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026